Oklo Inc S-1, filed May 9, 2025
Oklo Inc. (OKLO)
SECURITIES AND EXCHANGE COMMISSION
THE SECURITIES ACT OF 1933
| |
Delaware
(State or Other Jurisdiction of Incorporation or Organization)
|
| |
4911
(Primary Standard Industrial Classification
Code Number) |
| |
86-2292473
(I.R.S. Employer Identification No.)
|
|
Santa Clara, California 95054 (650) 550-0127
Oklo Inc.
3190 Coronado Dr.
Santa Clara, California 95054 (650) 550-0127
Latham & Watkins LLP
811 Main Street, Suite 3700
Houston, Texas 77002
(713) 546 -5400
| |
Large accelerated filer
☐
|
| |
Accelerated filer
☐
|
|
| |
Non-accelerated filer
☒
|
| |
Smaller reporting company
☒
|
|
| |
Emerging growth company
☒
|
| | ||
| | | |
Page
|
| |||
| | | | | i | | | |
| | | | | ii | | | |
| | | | | iv | | | |
| | | | | 1 | | | |
| | | | | 5 | | | |
| | | | | 6 | | | |
| | | | | 8 | | | |
| | | | | 41 | | | |
| | | | | 42 | | | |
| | | | | 43 | | | |
| | | | | 44 | | | |
| | | | | 59 | | | |
| | | | | 66 | | | |
| | | | | 73 | | | |
| | | | | 79 | | | |
| | | | | 81 | | | |
| | | | | 82 | | | |
| | | | | 84 | | | |
| | | | | 87 | | | |
| | | | | 92 | | | |
| | | | | 94 | | | |
| | | | | 94 | | | |
| | | | | 94 | | | |
| | | | | F-1 | | | |
| | | |
Years Ended December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| | | |
(in thousands)
|
| |||||||||
|
Net cash used in operating activities
|
| | | $ | (38,390) | | | | | $ | (15,998) | | |
|
Net cash used in investing activities
|
| | | | (175,774) | | | | | | (83) | | |
|
Net cash provided by financing activities
|
| | | | 301,428 | | | | | | 16,295 | | |
|
Net increase in cash and cash equivalents
|
| | | $ | 87,264 | | | | | $ | 214 | | |
|
Cash and cash equivalents, end of year
|
| | | $ | 97,132 | | | | | $ | 9,868 | | |
| | | |
Years Ended December 31,
|
| |
2024 versus 2023
|
| ||||||||||||||||||
| | | |
2024
|
| |
2023
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
| | | |
(in thousands)
|
| |||||||||||||||||||||
| Operating expenses | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Research and development
|
| | | $ | 26,711 | | | | | $ | 9,763 | | | | | $ | 16,948 | | | | | | 173.6% | | |
|
General and administrative
|
| | | | 26,090 | | | | | | 8,873 | | | | | | 17,217 | | | | | | 194.0% | | |
|
Total operating expenses
|
| | | | 52,801 | | | | | | 18,636 | | | | | | 34,165 | | | | | | 183.3% | | |
|
Loss from operations
|
| | | | (52,801) | | | | | | (18,636) | | | | | | (34,165) | | | | | | 183.3% | | |
| Other (income) loss | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Change in fair value of simple agreement for future equity
|
| | | | (27,864) | | | | | | (13,717) | | | | | | (14,147) | | | | | | 103.1% | | |
|
Interest and dividend income
|
| | | | 7,732 | | | | | | 180 | | | | | | 7,552 | | | | | | NM | | |
|
Total other loss
|
| | | | (20,132) | | | | | | (13,537) | | | | | | (6,595) | | | | | | 48.7% | | |
|
Loss before income taxes
|
| | | | (72,933) | | | | | | (32,173) | | | | | | (40,760) | | | | | | 126.7% | | |
|
Income taxes
|
| | | | (683) | | | | | | — | | | | | | (683) | | | | | | NM | | |
|
Net loss
|
| | | $ | (73,616) | | | | | $ | (32,173) | | | | | $ | (41,443) | | | | | | 128.8% | | |
| | | |
Years Ended December 31,
|
| |
2024 versus 2023
|
| ||||||||||||||||||
| | | |
2024
|
| |
2023
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
| | | |
(in thousands)
|
| |||||||||||||||||||||
|
Total research and development expenses
|
| | | $ | 26,711 | | | | | $ | 9,763 | | | | | $ | 16,948 | | | | | | 173.6% | | |
| | | |
Years Ended December 31,
|
| |
2024 versus 2023
|
| ||||||||||||||||||
| | | |
2024
|
| |
2023
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
| | | |
(in thousands)
|
| |||||||||||||||||||||
|
Total research and development expenses
|
| | | $ | 26,090 | | | | | $ | 8,873 | | | | | $ | 17,217 | | | | | | 194.0% | | |
| | | |
Years Ended December 31,
|
| |
2024 versus 2023
|
| ||||||||||||||||||
| | | |
2024
|
| |
2023
|
| |
$ Change
|
| |
% Change
|
| ||||||||||||
| | | |
(in thousands)
|
| |||||||||||||||||||||
|
Change in fair value of SAFEs
|
| | | $ | (27,864) | | | | | $ | (13,717) | | | | | $ | (14,147) | | | | | | 103.1% | | |
|
Interest and dividend income
|
| | | | 7,732 | | | | | | 180 | | | | | | 7,552 | | | | | | NM | | |
|
Total other loss
|
| | | $ | (20,132) | | | | | $ | (13,537) | | | | | $ | (6,595) | | | | | | 48.7% | | |
|
Name
|
| |
Age
|
| |
Position(s)
|
|
| Executive Officers: | | | | | | | |
| Jacob DeWitte | | |
39
|
| | Chairman and Chief Executive Officer | |
| R. Craig Bealmear | | |
58
|
| | Chief Financial Officer | |
| Caroline Cochran | | |
42
|
| | Chief Operating Officer and Director | |
| Non-Employee Directors: | | | | | | | |
| Lieutenant General (Ret.) John Jansen(1)(2) | | |
62
|
| | Director | |
| Richard W. Kinzley(1)(2) | | |
59
|
| | Director | |
| Michael Klein(3) | | |
61
|
| | Director | |
| Michael Thompson(2) | | |
48
|
| | Director | |
| Daniel B. Poneman(3) | | |
69
|
| | Director | |
|
Name
|
| |
Year
|
| |
Salary
($) |
| |
Bonus
($) |
| |
Stock Awards
($)(1) |
| |
Option
Awards ($)(2) |
| |
All Other
Compensation ($) |
| |
Total
($) |
| |||||||||||||||||||||
|
Jacob DeWitte
Co-Founder, Chief Executive Officer |
| | | | 2024 | | | | | | 425,095 | | | | | | 587,548(3) | | | | | | 2,622,475 | | | | | | — | | | | | | 13,800(4) | | | | | | 3,648,918 | | |
| | | | 2023 | | | | | | 211,077 | | | | | | 112,000 | | | | | | — | | | | | | — | | | | | | 8,615 | | | | | | 331,692 | | | ||
|
Caroline Cochran
Co-Founder, Chief Operating Officer |
| | | | 2024 | | | | | | 357,981 | | | | | | 278,990(3) | | | | | | 1,835,730 | | | | | | — | | | | | | 13,716(4) | | | | | | 2,486,417 | | |
| | | | 2023 | | | | | | 211,077 | | | | | | 112,000 | | | | | | — | | | | | | — | | | | | | 8,969 | | | | | | 332,046 | | | ||
|
R. Craig Bealmear(5)
Chief Financial Officer |
| | | | 2024 | | | | | | 362,308 | | | | | | 281,154(3) | | | | | | 1,835,730 | | | | | | — | | | | | | 13,308(4) | | | | | | 2,492,500 | | |
| | | | 2023 | | | | | | 115,385 | | | | | | 62,500 | | | | | | — | | | | | | 3,015,873 | | | | | | 1,846 | | | | | | 3,195,604 | | | ||
|
Named Executive Officer
|
| |
Title
|
| |
Annual Base
Salary ($) |
| |
Initial Grant Target
Grant Date Value ($) |
| ||||||
|
Jacob DeWitte
|
| |
Chief Executive Officer
|
| | | | 500,000 | | | | | | 3,000,000 | | |
|
Caroline Cochran
|
| |
Chief Operating Officer
|
| | | | 400,000 | | | | | | 2,100,000 | | |
|
R. Craig Bealmear
|
| |
Chief Financial Officer
|
| | | | 400,000 | | | | | | 2,100,000 | | |
| | | | | | | | | |
Option Awards
|
| |
Stock Awards
|
| ||||||||||||||||||||||||||||||
|
Name
|
| |
Grant Date
|
| |
Number of
Securities Underlying Unexercised Options (#) Exercisable |
| |
Number of
Securities Underlying Unexercised Options (#) Unexercisable |
| |
Option
Exercise Price ($) |
| |
Option
Expiration Date |
| |
Number of
Shares or Units of Stock That Have Not Vested (#) |
| |
Market
Value of Shares or Units of Stock That Have Not Vested ($) |
| |||||||||||||||||||||
|
Jacob DeWitte
|
| | | | 7/10/2024 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 280,899(1) | | | | | | 5,963,486 | | |
|
Caroline Cochran
|
| | | | 7/10/2024 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 196,629(1) | | | | | | 4,174,434 | | |
|
R. Craig Bealmear
|
| | | | 7/10/2024 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 196,629(1) | | | | | | 4,174,434 | | |
| | | | | | 12/23/2023 | | | | | | 353,536 | | | | | | 972,223(2) | | | | | | 3.18 | | | | | | 12/23/2033 | | | | | | — | | | | | | — | | |
|
Name
|
| |
Fees Earned
or Paid in Cash ($) |
| |
Stock
Awards ($)(1) |
| |
Total
($) |
| |||||||||
|
Sam Altman(2)
|
| | | | — | | | | | | — | | | | | | — | | |
|
Michael Klein(2)
|
| | | | — | | | | | | — | | | | | | — | | |
|
Richard W. Kinzley
|
| | | | 58,104 | | | | | | 131,124 | | | | | | 189,228 | | |
|
Lieutenant General (Ret.) John Jansen
|
| | | | 54,876 | | | | | | 131,124 | | | | | | 186,000 | | |
|
Chris Wright
|
| | | | 45,192 | | | | | | 131,124 | | | | | | 176,316 | | |
|
Name
|
| |
Stock
Awards Outstanding |
| |||
|
Sam Altman
|
| | | | — | | |
|
Michael Klein
|
| | | | — | | |
|
Richard W. Kinzley
|
| | | | 16,854 | | |
|
Lieutenant General (Ret.) John Jansen
|
| | | | 16,854 | | |
|
Chris Wright
|
| | | | 16,854 | | |
|
Name and Address of Beneficial Owner(1)
|
| |
Number of
Shares |
| |
% of
Ownership |
| ||||||
| Directors and Named Executive Officers | | | | | | | | | | | | | |
|
Jacob DeWitte(2)
|
| | | | 25,402,712 | | | | | | 18.24% | | |
|
Caroline Cochran(2)
|
| | | | 25,402,712 | | | | | | 18.24% | | |
|
Michael Klein(3)
|
| | | | 500,000 | | | | | | * | | |
|
Richard W. Kinzley(4)
|
| | | | 21,854 | | | | | | * | | |
|
R. Craig Bealmear(5)
|
| | | | 547,351 | | | | | | * | | |
|
Lieutenant General (Ret.) John Jansen(6)
|
| | | | 22,854 | | | | | | * | | |
|
Michael Thompson
|
| | | | — | | | | | | — | | |
|
Daniel B. Poneman
|
| | | | — | | | | | | — | | |
|
All directors and executive officers as a group (8 individuals)
|
| | | | 26,531,771 | | | | | | 18.96% | | |
|
Name of Selling Holder and Addresses
|
| |
Number of
Shares of Common Stock Owned Prior to Offering |
| |
Maximum
Number of Shares of Common Stock to be Sold Pursuant to this Prospectus |
| |
Number of
Shares of Common Stock Owned After Offering |
| |
Percentage of
Outstanding Common Stock Beneficially Owned After the Offered Shares of Common Stock are Sold |
| ||||||||||||
|
8090 Industries Decarbonization Fund II LP
|
| | | | 23,046 | | | | | | 23,046 | | | | | | — | | | | | | — | | |
|
AA13 L.L.C.
|
| | | | 1,427 | | | | | | 1,427 | | | | | | — | | | | | | — | | |
|
Asymmetry Ventures Fund I, A Series of Asymmetry Ventures, LP
|
| | | | 3,172 | | | | | | 3,172 | | | | | | — | | | | | | — | | |
|
At Fund I, A Series of Ax-Rn-Funds, LP
|
| | | | 43,607 | | | | | | 43,607 | | | | | | — | | | | | | — | | |
|
Atypical LLC
|
| | | | 19,716 | | | | | | 19,716 | | | | | | — | | | | | | — | | |
|
Atypical Ventures Fund I, L.P.
|
| | | | 27,684 | | | | | | 27,684 | | | | | | — | | | | | | — | | |
|
Calvin French-Owen
|
| | | | 1,903 | | | | | | 1,903 | | | | | | — | | | | | | — | | |
|
Chad Morris
|
| | | | 713 | | | | | | 713 | | | | | | — | | | | | | — | | |
|
Christopher Robert Boshuizen
|
| | | | 3,569 | | | | | | 3,569 | | | | | | — | | | | | | — | | |
|
Crunch Fund III, L.P.
|
| | | | 54,727 | | | | | | 54,727 | | | | | | — | | | | | | — | | |
|
Data Collective IV, L.P.
|
| | | | 33,879 | | | | | | 33,879 | | | | | | — | | | | | | — | | |
|
Divergent Capital I, L.P.
|
| | | | 57,105 | | | | | | 57,105 | | | | | | — | | | | | | — | | |
|
Name of Selling Holder and Addresses
|
| |
Number of
Shares of Common Stock Owned Prior to Offering |
| |
Maximum
Number of Shares of Common Stock to be Sold Pursuant to this Prospectus |
| |
Number of
Shares of Common Stock Owned After Offering |
| |
Percentage of
Outstanding Common Stock Beneficially Owned After the Offered Shares of Common Stock are Sold |
| ||||||||||||
|
At Fund II, A Series of Ax-Rn-Funds, LP
|
| | | | 5,673 | | | | | | 5,673 | | | | | | — | | | | | | — | | |
|
Hemisphere Ventures Frontier Tech Fund 2019,
A Series of Hemisphere Ventures, LP |
| | | | 25,380 | | | | | | 25,380 | | | | | | — | | | | | | — | | |
|
Mark Hilse
|
| | | | 5,392 | | | | | | 5,392 | | | | | | — | | | | | | — | | |
|
Patrick Woodson
|
| | | | 1,427 | | | | | | 1,427 | | | | | | — | | | | | | — | | |
|
Pmf Fund, A Series of Angel Deal Holdings, LP
|
| | | | 12,690 | | | | | | 12,690 | | | | | | — | | | | | | — | | |
|
Scouts 2020 LLC
|
| | | | 3,172 | | | | | | 3,172 | | | | | | — | | | | | | — | | |
|
Seachange Fund VII, LLC
|
| | | | 27,655 | | | | | | 27,655 | | | | | | — | | | | | | — | | |
|
Stuart Gardner
|
| | | | 1,213 | | | | | | 1,213 | | | | | | — | | | | | | — | | |
|
Thomas Eiden
|
| | | | 640,125 | | | | | | 640,125 | | | | | | — | | | | | | — | | |
|
Thomas James
|
| | | | 4,497 | | | | | | 4,497 | | | | | | — | | | | | | — | | |
|
Twenty Nineteen Ventures, LLC
|
| | | | 3,172 | | | | | | 3,172 | | | | | | — | | | | | | — | | |
|
Type One Fund II, A Series of Type One Fund LP
|
| | | | 14,276 | | | | | | 14,276 | | | | | | — | | | | | | — | | |
|
YC Holdings II, LLC
|
| | | | 79,959 | | | | | | 79,959 | | | | | | — | | | | | | — | | |
| | | |
Page
|
| |||
| | | | | F-2 | | | |
| | | | | F-3 | | | |
| | | | | F-4 | | | |
| | | | | F-5 | | | |
| | | | | F-6 | | | |
| | | | | F-7 | | | |
| | | | | F-8 | | | |
| | | | | F-9 | | | |
(in thousands, except share data)
| | | |
As of December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| Assets | | | | | | | | | | | | | |
| Current assets: | | | | | | | | | | | | | |
|
Cash and cash equivalents
|
| | | $ | 97,132 | | | | | $ | 9,868 | | |
|
Marketable debt securities
|
| | | | 130,682 | | | | | | — | | |
|
Prepaid and other current assets
|
| | | | 4,125 | | | | | | 4,331 | | |
|
Total current assets
|
| | | | 231,939 | | | | | | 14,199 | | |
|
Marketable debt securities
|
| | | | 47,473 | | | | | | — | | |
|
Property and equipment, net
|
| | | | 1,202 | | | | | | 578 | | |
|
Operating lease right-of-use assets
|
| | | | 982 | | | | | | 83 | | |
|
Other assets
|
| | | | 140 | | | | | | 25 | | |
|
Total assets
|
| | | $ | 281,736 | | | | | $ | 14,885 | | |
| Liabilities and stockholders’ equity (deficit) | | | | | | | | | | | | | |
| Current liabilities: | | | | | | | | | | | | | |
|
Accounts payable
|
| | | $ | 2,970 | | | | | $ | 2,274 | | |
|
Accrued expenses and other
|
| | | | 1,885 | | | | | | 836 | | |
|
Operating lease liabilities
|
| | | | 481 | | | | | | 94 | | |
|
Total current liabilities
|
| | | | 5,336 | | | | | | 3,204 | | |
|
Operating lease liabilities, net of current portion
|
| | | | 543 | | | | | | — | | |
|
Simple agreements for future equity
|
| | | | — | | | | | | 46,042 | | |
|
Right of first refusal liability
|
| | | | 25,000 | | | | | | — | | |
|
Total liabilities
|
| | | | 30,879 | | | | | | 49,246 | | |
| Commitments and contingencies (Note 15) | | | | | | | | | | | | | |
| Stockholders’ equity (deficit): | | | | | | | | | | | | | |
|
Class A common stock, $0.0001 par value – 500,000,000 shares authorized; 137,706,596 and 69,242,940 shares issued and outstanding as of December 31, 2024 and 2023, respectively
|
| | | | 14 | | | | | | 7 | | |
|
Additional paid-in capital
|
| | | | 383,739 | | | | | | 27,125 | | |
|
Accumulated deficit
|
| | | | (135,109) | | | | | | (61,493) | | |
|
Accumulated other comprehensive income
|
| | | | 2,213 | | | | | | — | | |
|
Total stockholders’ equity (deficit)
|
| | | | 250,857 | | | | | | (34,361) | | |
|
Total liabilities and stockholders’ equity
|
| | | $ | 281,736 | | | | | $ | 14,885 | | |
(in thousands, except share data)
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| Operating expenses | | | | | | | | | | | | | |
|
Research and development
|
| | | $ | 26,711 | | | | | $ | 9,763 | | |
|
General and administrative
|
| | | | 26,090 | | | | | | 8,873 | | |
|
Total operating expenses
|
| | | | 52,801 | | | | | | 18,636 | | |
|
Loss from operations
|
| | | | (52,801) | | | | | | (18,636) | | |
| Other income (loss) | | | | | | | | | | | | | |
|
Change in fair value of simple agreements for future equity
|
| | | | (27,864) | | | | | | (13,717) | | |
|
Interest and dividend income
|
| | | | 7,732 | | | | | | 180 | | |
|
Total other income (loss)
|
| | | | (20,132) | | | | | | (13,537) | | |
|
Loss before income taxes
|
| | | | (72,933) | | | | | | (32,173) | | |
|
Income taxes
|
| | | | (683) | | | | | | — | | |
|
Net loss
|
| | | $ | (73,616) | | | | | $ | (32,173) | | |
| Net loss per share: | | | | | | | | | | | | | |
|
Basic and diluted – Class A common stock
|
| | | $ | (0.74) | | | | | $ | (0.47) | | |
|
Weighted-average common shares outstanding – basic and diluted – Class A common stock
|
| | | | 98,910,013 | | | | | | 68,891,996 | | |
(in thousands)
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Net loss
|
| | | $ | (73,616) | | | | | $ | (32,173) | | |
| Other comprehensive income: | | | | | | | | | | | | | |
|
Change in unrealized gains on marketable debt securities
|
| | | | 2,213 | | | | | | — | | |
|
Total comprehensive loss
|
| | | $ | (71,403) | | | | | $ | (32,173) | | |
(in thousands, except share data)
| | | |
Redeemable
Convertible Preferred Stock |
| | |
Common Stock
|
| |
Class A
Common Stock |
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Accumulated
Other Comprehensive Income |
| |
Total
Stockholders’ Equity |
| |||||||||||||||||||||||||||||||||||||||
| | | |
Shares
|
| |
Amount
|
| | |
Shares(1)
|
| |
Par
Value(1) |
| |
Shares
|
| |
Par
Value |
| ||||||||||||||||||||||||||||||||||||||||||
|
Balance as of December 31, 2023, as recast
|
| | | | — | | | | | $ | — | | | | | | | — | | | | | $ | — | | | | | | 69,242,940 | | | | | $ | 7 | | | | | $ | 27,125 | | | | | $ | (61,493) | | | | | $ | — | | | | | $ | (34,361) | | |
|
Exercise of stock options
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 2,256,157 | | | | | | — | | | | | | 1,044 | | | | | | — | | | | | | — | | | | | | 1,044 | | |
|
Stock-based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 12,484 | | | | | | — | | | | | | — | | | | | | 12,484 | | |
|
Issuance of Class A common stock in connection with the Business Combination, net of transaction costs (Note 3)
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 43,099,811 | | | | | | 4 | | | | | | 258,951 | | | | | | — | | | | | | — | | | | | | 258,955 | | |
|
Issuance of Class A common stock upon conversion of simple agreements for future equity immediately before the Business Combination (Note 3)
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 8,407,894 | | | | | | 1 | | | | | | 84,137 | | | | | | — | | | | | | — | | | | | | 84,138 | | |
|
Change in unrealized gains on marketable debt securities
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 2,213 | | | | | | 2,213 | | |
|
Issuance of Class A common stock in connection with earnout awards
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 14,699,794 | | | | | | 2 | | | | | | (2) | | | | | | — | | | | | | — | | | | | | — | | |
|
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (73,616) | | | | | | — | | | | | | (73,616) | | |
|
Balance as of December 31, 2024
|
| | | | — | | | | | $ | — | | | | | | $ | — | | | | | $ | — | | | | | | 137,706,596 | | | | | $ | 14 | | | | | $ | 383,739 | | | | | $ | (135,109) | | | | | $ | 2,213 | | | | | $ | 250,857 | | |
(in thousands, except share data)
| | | |
Redeemable
Convertible Preferred Stock |
| | |
Common Stock
|
| |
Class A
Common Stock |
| |
Additional
Paid-in Capital |
| |
Accumulated
Deficit |
| |
Accumulated
Other Comprehensive Income |
| |
Total
Stockholders’ Equity |
| |||||||||||||||||||||||||||||||||||||||
| | | |
Shares
|
| |
Amount
|
| | |
Shares(1)
|
| |
Par
Value(1) |
| |
Shares
|
| |
Par
Value |
| ||||||||||||||||||||||||||||||||||||||||||
|
Balance as of January 1, 2023, as previously reported
|
| | | | 6,585,881 | | | | | $ | 25,032 | | | | | | | 4,771,025 | | | | | $ | — | | | | | | — | | | | | $ | — | | | | | $ | 1,209 | | | | | $ | (29,320) | | | | | $ | — | | | | | $ | (28,111) | | |
|
Retroactive application of reverse recapitalization (Note 3)
|
| | | | (6,585,881) | | | | | | (25,032) | | | | | | | (4,771,025) | | | | | | — | | | | | | 68,845,564 | | | | | | 7 | | | | | | 25,025 | | | | | | — | | | | | | — | | | | | | 25,032 | | |
|
Balance as of January 1, 2023, after effect of reverse recapitalization
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 68,845,564 | | | | | | 7 | | | | | | 26,234 | | | | | | (29,320) | | | | | | — | | | | | | (3,079) | | |
|
Exercise of stock options
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | 397,376 | | | | | | — | | | | | | 114 | | | | | | — | | | | | | — | | | | | | 114 | | |
|
Stock-based compensation
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 777 | | | | | | — | | | | | | — | | | | | | 777 | | |
|
Net loss
|
| | | | — | | | | | | — | | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | (32,173) | | | | | | — | | | | | | (32,173) | | |
|
Balance as of December 31, 2023
|
| | | | — | | | | | $ | — | | | | | | | — | | | | | $ | — | | | | | | 69,242,940 | | | | | $ | 7 | | | | | $ | 27,125 | | | | | $ | (61,493) | | | | | $ | — | | | | | $ | (34,361) | | |
(in thousands)
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| Cash flows from operating activities | | | | | | | | | | | | | |
|
Net loss
|
| | | $ | (73,616) | | | | | $ | (32,173) | | |
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | | | | | | |
|
Depreciation and amortization
|
| | | | 268 | | | | | | 75 | | |
|
Change in fair value of simple agreements for future equity
|
| | | | 27,864 | | | | | | 13,717 | | |
|
Accretion of discount on marketable debt securities
|
| | | | (520) | | | | | | — | | |
|
Stock-based compensation
|
| | | | 12,484 | | | | | | 777 | | |
|
Change in operating assets and liabilities:
|
| | | | | | | | | | | | |
|
Prepaid and other current assets
|
| | | | (1,520) | | | | | | (126) | | |
|
Other assets
|
| | | | (115) | | | | | | 26 | | |
|
Accounts payable
|
| | | | (1,762) | | | | | | 1,344 | | |
|
Accrued expenses and other
|
| | | | (1,504) | | | | | | 384 | | |
|
Operating lease right-of-use assets and liabilities
|
| | | | 31 | | | | | | (22) | | |
|
Net cash used in operating activities
|
| | | | (38,390) | | | | | | (15,998) | | |
| Cash flows from investing activities | | | | | | | | | | | | | |
|
Purchases of property and equipment
|
| | | | (352) | | | | | | (83) | | |
|
Purchases of marketable debt securities
|
| | | | (291,620) | | | | | | — | | |
|
Proceeds from redemptions of marketable debt securities
|
| | | | 116,198 | | | | | | — | | |
|
Net cash used in investing activities
|
| | | | (175,774) | | | | | | (83) | | |
| Cash flows from financing activities | | | | | | | | | | | | | |
|
Proceeds from recapitalization
|
| | | | 276,210 | | | | | | — | | |
|
Proceeds from exercise of stock options
|
| | | | 1,044 | | | | | | 114 | | |
|
Proceeds from right of first refusal liability
|
| | | | 25,000 | | | | | | — | | |
|
Proceeds from simple agreements for future equity
|
| | | | 10,232 | | | | | | 19,325 | | |
|
Payment of deferred issuance costs
|
| | | | (11,058) | | | | | | (3,144) | | |
|
Net cash provided by financing activities
|
| | | | 301,428 | | | | | | 16,295 | | |
|
Net increase in cash and cash equivalents
|
| | | | 87,264 | | | | | | 214 | | |
|
Cash and cash equivalents – beginning of year
|
| | | | 9,868 | | | | | | 9,654 | | |
|
Cash and cash equivalents – end of year
|
| | | $ | 97,132 | | | | | $ | 9,868 | | |
| Supplemental disclosures of cash flow information | | | | | | | | | | | | | |
|
Cash paid for interest
|
| | | $ | — | | | | | $ | — | | |
|
Cash paid for income taxes
|
| | | | 907 | | | | | | — | | |
| Supplemental noncash investing and financing activities | | | | | | | | | | | | | |
|
Reclassification of deferred issuance costs in connection with business combination
|
| | | $ | 5,510 | | | | | $ | — | | |
|
Reclassification of simple agreements for future equity in connection with business combination
|
| | | | 84,138 | | | | | | — | | |
|
Deferred issuance costs included in accounts payable
|
| | | | 1,906 | | | | | | 443 | | |
|
Deferred issuance costs included in accrued expense and other
|
| | | | — | | | | | | 122 | | |
|
Purchases of computer software in accounts payable and accrued expense and other
|
| | | | 540 | | | | | | 392 | | |
(in thousands, except share data and amounts, and exchange ratio)
| | Furniture and fixtures | | | 7 years | |
| | Computers | | | 3 to 7 years | |
| | Software | | | 3 years | |
| | Leasehold improvements | | |
Shorter of lease term or estimated useful life of the asset
|
|
| |
Cash proceeds from recapitalization
|
| | | $ | 276,210 | | |
| |
Add: accrued interest receivable
|
| | | | 44 | | |
| |
Add: advance to Legacy Oklo
|
| | | | 1,830 | | |
| |
Add: prepaid expenses
|
| | | | 4 | | |
| |
Less: transaction costs and advisor fees paid
|
| | | | (14,662) | | |
| |
Less: advisor fees for Earnout Shares
|
| | | | (1,906) | | |
| |
Cash and other assets acquired from the Business Combination
|
| | | | 261,520 | | |
| |
Less: accounts payable
|
| | | | (12) | | |
| |
Less: accrued expenses
|
| | | | (45) | | |
| |
Less: excise tax payable
|
| | | | (2,159) | | |
| |
Less: income taxes payable
|
| | | | (349) | | |
| |
Net assets from the Business Combination recorded on the consolidated stockholders’ equity (deficit)
|
| | | $ | 258,955 | | |
| | | |
Class A
Common Stock(1) |
| |||
|
Legacy Oklo stockholders(2)
|
| | | | 78,996,459 | | |
|
Sponsor stockholders (as defined in Note 11)(3)
|
| | | | 13,950,000 | | |
|
AltC public stockholders (as defined in Note 11)(4)
|
| | | | 29,149,811 | | |
|
Total AltC stockholders
|
| | | | 43,099,811 | | |
|
Total Class A common stock
|
| | | | 122,096,270 | | |
| | | |
As of December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Prepaid expense
|
| | | $ | 2,119 | | | | | $ | 370 | | |
|
Deferred issuance costs
|
| | | | — | | | | | | 3,710 | | |
|
Costs-share receivables
|
| | | | 600 | | | | | | 126 | | |
|
Accrued interest receivable
|
| | | | 1,138 | | | | | | — | | |
|
Rent security
|
| | | | 143 | | | | | | — | | |
|
Refundable deposit
|
| | | | 125 | | | | | | 125 | | |
|
Total prepaid and other current assets
|
| | | $ | 4,125 | | | | | $ | 4,331 | | |
| | | |
As of December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Computers and equipment
|
| | | $ | 366 | | | | | $ | 197 | | |
|
Furniture, fixtures and machinery
|
| | | | 146 | | | | | | 65 | | |
|
Software
|
| | | | 1,020 | | | | | | 392 | | |
|
Leasehold improvements
|
| | | | 45 | | | | | | 31 | | |
|
Total property and equipment, gross
|
| | | | 1,577 | | | | | | 685 | | |
|
Less accumulated depreciation and amortization
|
| | | | (375) | | | | | | (107) | | |
|
Total property and equipment, net
|
| | | $ | 1,202 | | | | | $ | 578 | | |
| | | |
As of December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Accrued professional fees
|
| | | $ | 652 | | | | | $ | — | | |
|
Accrued payroll and bonuses
|
| | | | 636 | | | | | | 197 | | |
|
Credit card liabilities
|
| | | | 261 | | | | | | 156 | | |
|
Franchise and income taxes payable
|
| | | | 202 | | | | | | — | | |
|
General accrued expenses
|
| | | | 134 | | | | | | 483 | | |
|
Total accrued expenses and other
|
| | | $ | 1,885 | | | | | $ | 836 | | |
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Operating lease costs during the year
|
| | | $ | 321 | | | | | $ | 340 | | |
|
Cash payments included in the measurement of operating lease liabilities during the year
|
| | | $ | 289 | | | | | $ | 225 | | |
|
Operating lease liabilities arising from obtaining lease right-of-use assets during the year
|
| | | $ | 1,185 | | | | | $ | — | | |
|
Weighted-average remaining lease term (in months) as of year-end
|
| | | | 24 | | | | | | 5 | | |
|
Weighted-average discount rate during the year
|
| | | | 8.76% | | | | | | 6.85% | | |
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| Operating lease costs: | | | | | | | | | | | | | |
|
Research and development
|
| | | $ | 234 | | | | | $ | 210 | | |
|
Sales, general and administrative
|
| | | | 87 | | | | | | 130 | | |
|
Total operating lease costs(1)
|
| | | $ | 321 | | | | | $ | 340 | | |
| |
2025
|
| | | $ | 548 | | |
| |
2026
|
| | | | 566 | | |
| |
Minimum lease payments
|
| | | | 1,114 | | |
| |
Less imputed interest
|
| | | | (90) | | |
| |
Present value of operating lease liabilities
|
| | | $ | 1,024 | | |
| |
Current portion of operating lease liabilities
|
| | | $ | 481 | | |
| |
Noncurrent portion of operating lease liabilities
|
| | | | 543 | | |
| |
Total operating lease liabilities
|
| | | $ | 1,024 | | |
| | | |
Amortized
Cost(1) |
| |
Unrealized
Gains |
| |
Unrealized
Losses |
| |
Fair Value
|
| |
Cash and
Cash Equivalents |
| |
Current
Marketable Securities |
| |
Noncurrent
Marketable Securities |
| |||||||||||||||||||||
|
Cash
|
| | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | — | | | | | $ | 3,020 | | | | | $ | — | | | | | $ | — | | |
| Level 1: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Money market funds
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | 94,112 | | | | | | — | | | | | | — | | |
|
U.S. Treasury securities
|
| | | | 156,040 | | | | | | 1,688 | | | | | | (6) | | | | | | 157,722 | | | | | | — | | | | | | 110,249 | | | | | | 47,473 | | |
|
Subtotal
|
| | | | 156,040 | | | | | | 1,688 | | | | | | (6) | | | | | | 157,722 | | | | | | 94,112 | | | | | | 110,249 | | | | | | 47,473 | | |
| Level 2(2): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Commercial paper
|
| | | | 19,902 | | | | | | 531 | | | | | | — | | | | | | 20,433 | | | | | | — | | | | | | 20,433 | | | | | | — | | |
|
Total
|
| | | $ | 175,942 | | | | | $ | 2,219 | | | | | $ | (6) | | | | | $ | 178,155 | | | | | $ | 97,132 | | | | | $ | 130,682 | | | | | $ | 47,473 | | |
| |
Due within 1 year
|
| | | $ | 130,682 | | |
| |
Due after 1 year through 5 years
|
| | | | 47,473 | | |
| |
Total fair value
|
| | | $ | 178,155 | | |
|
Legacy Oklo SAFEs
|
| |
Outstanding
Principal Balance of SAFEs Before Closing |
| |
Legacy Oklo
Price Per Share Upon Conversion |
| |
Legacy Oklo
Common Stock Issuable |
| |
Exchange
Ratio |
| |
Class A
Common Stock Issued at Closing(1) |
| |||||||||||||||
|
Valuation cap of $300,000,000
|
| | | $ | 13,995 | | | | | $ | 22.445945 | | | | | | 623,487 | | | | | | 6.062 | | | | | | 3,779,578 | | |
|
Valuation cap of $500,000,000
|
| | | | 28,562 | | | | | | 37.409909 | | | | | | 763,496 | | | | | | 6.062 | | | | | | 4,628,316 | | |
|
Total
|
| | | $ | 42,557 | | | | | | | | | | | | 1,386,983 | | | | | | | | | | | | 8,407,894 | | |
| |
Asset volatility(1)
|
| | 85.8% | |
| |
Risk-free rate(2)
|
| | 3.8% | |
| |
Expected term(3)
|
| | 60 months | |
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Beginning balance
|
| | | $ | 46,042 | | | | | $ | 13,340 | | |
|
SAFEs issued during the period
|
| | | | 10,232 | | | | | | 18,985 | | |
|
Change in fair value during the period(1)
|
| | | | 27,864 | | | | | | 13,717 | | |
|
Change in fair value upon conversion on SAFEs at Closing
|
| | | | (84,138) | | | | | | — | | |
|
Ending balance
|
| | | $ | — | | | | | $ | 46,042 | | |
|
Preferred Stock Series
|
| |
Shares
Issued and Outstanding Before Closing(1) |
| |
Exchange
Ratio |
| |
Class A
Common Stock Issued at Closing(1) |
| |||||||||
|
Preferred Stock Series A-1
|
| | | | 4,526,703 | | | | | | 6.062 | | | | | | 27,440,874 | | |
|
Preferred Stock Series A-2
|
| | | | 55,135 | | | | | | 6.062 | | | | | | 334,228 | | |
|
Preferred Stock Series A-3
|
| | | | 2,004,043 | | | | | | 6.062 | | | | | | 12,148,509 | | |
|
Totals
|
| | | | 6,585,881 | | | | | | | | | | | | 39,923,611 | | |
| | | |
Years Ended December 31,
|
| |||
| | | |
2024
|
| |
2023
|
|
|
Expected volatility
|
| |
79.67%
|
| |
75.63% – 78.47%
|
|
|
Expected dividend yield
|
| |
0%
|
| |
0%
|
|
|
Risk-free interest rate
|
| |
4.08%
|
| |
3.64% – 4.87%
|
|
|
Expected term
|
| |
6.3 years
|
| |
6.3 years
|
|
| | | |
Number of
Shares |
| |
Weighted
Average Exercise Price |
| |
Weighted
Average Remaining Contractual Life (in years) |
| |||||||||
|
Class A common stock awards outstanding at January 1, 2024
|
| | | | 11,426,653 | | | | | $ | 1.59 | | | | | | 8.47 | | |
|
Granted
|
| | | | 351,717 | | | | | | 4.37 | | | | | | | | |
|
Exercised
|
| | | | (2,256,157) | | | | | | 0.46 | | | | | | | | |
|
Forfeited
|
| | | | (51,831) | | | | | | 3.18 | | | | | | | | |
|
Class A common stock awards outstanding at December 31, 2024
|
| | | | 9,470,382 | | | | | | 1.95 | | | | | | 7.91 | | |
|
Class A common stock awards exercisable at December 31, 2024
|
| | | | 3,256,613 | | | | | | 1.29 | | | | | | 6.96 | | |
|
Class A common stock awards not vested at December 31, 2024
|
| | | | 6,213,769 | | | | | | | | | | | | | | |
| | | |
Number of Units
|
| |
Weighted
Average Grant Date Fair Value |
| ||||||||||||
| | | |
Unvested
|
| |
Vested
|
| ||||||||||||
|
Restricted stock units, beginning balance
|
| | | | — | | | | | | — | | | | | | — | | |
|
Granted
|
| | | | 1,390,298 | | | | | | — | | | | | | 8.02 | | |
|
Vested
|
| | | | (134,832) | | | | | | 134,832 | | | | | | 7.78 | | |
|
Forfeited
|
| | | | (3,300) | | | | | | — | | | | | | 7.46 | | |
|
Restricted stock units outstanding at December 31, 2024
|
| | | | 1,252,166 | | | | | | 134,832 | | | | | | 8.02 | | |
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Research and development
|
| | | $ | 7,797 | | | | | $ | 398 | | |
|
General and administrative
|
| | | | 4,687 | | | | | | 379 | | |
|
Total costs charged to operations(1)
|
| | | $ | 12,484 | | | | | $ | 777 | | |
| | | |
As at December 31,
|
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
| Deferred tax assets: | | | | | | | | | | | | | |
|
Net operating loss carryforwards
|
| | | $ | 3,078 | | | | | $ | 2,320 | | |
|
R&D credit
|
| | | | 2,443 | | | | | | 1,424 | | |
|
Capitalized R&D expenses
|
| | | | 5,617 | | | | | | 2,647 | | |
|
Capitalized start-up expenses
|
| | | | 15,628 | | | | | | 4,652 | | |
|
Operating lease liabilities
|
| | | | 216 | | | | | | — | | |
|
Stock-based compensation
|
| | | | 394 | | | | | | 80 | | |
|
Depreciation and amortization
|
| | | | 73 | | | | | | 17 | | |
|
Accrued expenses
|
| | | | — | | | | | | 44 | | |
|
Deferred tax assets
|
| | | | 27,449 | | | | | | 11,184 | | |
|
Valuation allowance
|
| | | | (26,775) | | | | | | (11,184) | | |
|
Total deferred tax assets
|
| | | | 674 | | | | | | — | | |
| Deferred tax liabilities: | | | | | | | | | | | | | |
|
Right-of-use assets
|
| | | | (207) | | | | | | — | | |
|
Unrealized gain on marketable securities
|
| | | | (467) | | | | | | — | | |
|
Total deferred tax liabilities
|
| | | | (674) | | | | | | — | | |
|
Net deferred assets
|
| | | $ | — | | | | | $ | — | | |
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Federal taxes at statutory rate
|
| | | | 21.0% | | | | | | 21.0% | | |
|
State and local taxes, net of federal benefit
|
| | | | (0.7)% | | | | | | 0.2% | | |
|
Tax credit carryforward generated
|
| | | | 1.8% | | | | | | 1.9% | | |
|
Change in unrealized gains on marketable securities
|
| | | | (0.6)% | | | | | | 0.0% | | |
|
Valuation allowance
|
| | | | (21.4)% | | | | | | (13.7)% | | |
|
Nondeductible change in fair value of SAFE
|
| | | | (8.0)% | | | | | | (9.0)% | | |
|
Transaction costs
|
| | | | 2.1% | | | | | | 0.0% | | |
|
Interest expense
|
| | | | 1.6% | | | | | | 0.0% | | |
|
Stock-based compensation
|
| | | | 3.8% | | | | | | 0.0% | | |
|
Other differences
|
| | | | (0.5)% | | | | | | (0.4)% | | |
|
Effective Income Tax Rate
|
| | | | (0.9)% | | | | | | 0.0% | | |
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Valuation allowance for deferred tax assets – beginning of year
|
| | | $ | 11,184 | | | | | $ | 6,777 | | |
|
Change in valuation allowance for deferred tax assets during the year
|
| | | | 15,591 | | | | | | 4,407 | | |
|
Valuation allowance for deferred tax assets – end of year
|
| | | $ | 26,775 | | | | | $ | 11,184 | | |
| | | |
Years Ended
December 31, |
| |||||||||
| | | |
2024
|
| |
2023
|
| ||||||
|
Balance at beginning of year
|
| | | $ | — | | | | | $ | — | | |
|
Additions for tax positions taken in prior year
|
| | | | 142 | | | | | | — | | |
|
Additions for tax positions related to the current year
|
| | | | 129 | | | | | | — | | |
|
Balance at end of year
|
| | | $ | 271 | | | | | $ | — | | |
| |
SEC Registration Fee
|
| | | $ | 4,250.49 | | |
| |
FINRA Filing Fees
|
| | | $ | ** | | |
| |
Legal Fees and Expenses
|
| | | $ | ** | | |
| |
Accounting Fees and Expenses
|
| | | $ | ** | | |
| |
Miscellaneous Expenses
|
| | | $ | ** | | |
| |
Total
|
| | | $ | ** | | |
| |
Exhibit
Number |
| |
Description
|
|
| | 10.12 | | | Confidential Letter of Intent to Purchase Power, dated as of February 16, 2024, by and between Oklo Inc. and Equinix, Inc. (incorporated by reference to Exhibit 10.19 to the Company’s Registration Statement on Form S-4, as amended, filed by the registrant with the SEC on April 15, 2024). | |
| | 21.1 | | | | |
| | 23.1* | | | | |
| | 23.2* | | | | |
| | 24.1* | | | | |
| | 101.INS | | | XBRL Instance Document | |
| | 101.SCH | | | XBRL Taxonomy Extension Schema Document | |
| |
101.CAL
|
| | XBRL Taxonomy Extension Calculation Linkbase Document | |
| |
101.DEF
|
| | XBRL Taxonomy Extension Definition Linkbase Document | |
| | 101.LAB | | | XBRL Taxonomy Extension Label Linkbase Document | |
| | 104 | | | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |
| | 107* | | | |
Chief Executive Officer
| |
Signature
|
| |
Title
|
| |
Date
|
|
| |
/s/ Jacob DeWitte
Jacob DeWitte
|
| |
Chairman and Chief Executive Officer (Principal Executive Officer)
|
| |
May 8, 2025
|
|
| |
/s/ R. Craig Bealmear
R. Craig Bealmear
|
| |
Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer) |
| |
May 8, 2025
|
|
| |
/s/ Caroline Cochran
Caroline Cochran
|
| |
Chief Operating Officer and Director
|
| |
May 8, 2025
|
|
| |
/s/ John Jansen
Lieutenant General (Ret.) John Jansen
|
| |
Director
|
| |
May 8, 2025
|
|
| |
/s/ Richard W. Kinzley
Richard W. Kinzley
|
| |
Director
|
| |
May 8, 2025
|
|
| |
/s/ Michael Klein
Michael Klein
|
| |
Director
|
| |
May 8, 2025
|
|
| |
/s/ Michael Thompson
Michael Thompson
|
| |
Director
|
| |
May 8, 2025
|
|
| |
/s/ Daniel Poneman
Daniel Poneman
|
| |
Director
|
| |
May 8, 2025
|
|
Exhibit 5.1
| 811 Main Street, Suite 3700 | ||
| Houston, TX 77002 | ||
| Tel: +1.713.546.5400 Fax: +1.713.546.5401 | ||
| www.lw.com | ||
![]() |
FIRM / AFFILIATE OFFICES | |
| Austin | Milan | |
| Beijing | Munich | |
| Boston | New York | |
| Brussels | Orange County | |
| May 8, 2025 | Century City | Paris |
| Chicago | Riyadh | |
| Dubai | San Diego | |
| Düsseldorf | San Francisco | |
| Oklo Inc. | Frankfurt | Seoul |
| 3190 Coronado Dr. | Hamburg | Silicon Valley |
| Santa Clara, California 95054 | Hong Kong | Singapore |
| Houston | Tel Aviv | |
| London | Tokyo Los | |
| Angeles | Washington, D.C. | |
| Madrid | ||
Re: Oklo Inc. – Registration Statement on Form S-1
To the addressees set forth above:
We have acted as special counsel to Oklo Inc., a Delaware corporation (the “Company”), in connection with its filing on the date hereof with the Securities and Exchange Commission (the “Commission”) of a registration statement on Form S-1 (the “Registration Statement”) under the Securities Act of 1933, as amended (the “Act”), relating to the registration of the offer and sale from time to time, in each case, by the selling securityholders named in the Registration Statement (the “Selling Securityholders”), of 1,095,179 outstanding shares (the “Resale Shares”) of Class A common stock, par value $0.0001 per share, of the Company (the “common stock”).
This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or related prospectus or prospectus supplement (collectively, the “Prospectus”) other than as expressly stated herein with respect to the offer, sale or issuance, as applicable, of the Resale Shares and Earnout Shares.
As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the “DGCL”) and we express no opinion with respect to the applicability thereto, or the effect thereon, of the laws of any other jurisdiction or, in the case of Delaware, any other laws, or as to any matters of municipal law or the laws of any local agencies within any state.
Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof the Resale Shares have been duly authorized by all necessary corporate action of the Company and are validly issued, fully paid and nonassessable.
May 8, 2025
Page 2

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference to our firm contained in the Prospectus under the heading “Legal Matters.” In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.
| Sincerely, | |
| /s/ Latham & Watkins LLP |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of our report dated March 24, 2025, relating to the financial statements of Oklo Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ DELOITTE & TOUCHE
San Jose, California
May 8, 2025
Exhibit 23.2
Independent Registered Public Accounting Firm’s Consent
We consent to the use in this Registration Statement on Form S-1 of our report dated April 2, 2024, except for Notes 1, 2, 5, 7, 10, 11, 12, and 17, as to which the date is August 30, 2024, and except for Note 16 as to which the date is March 24, 2025, relating to the financial statements of Oklo, Inc. appearing in this Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Marcum llp
Marcum llp
Los Angeles, CA
May 8, 2025
